June 21, 2026
Shot drama: jab wins, comments rage
HPV jabs cut risk of dying from cervical cancer before 30 to almost zero
Comment section says: amazing lifesaver, but wow that headline is doing backflips
TLDR: A major England study found the HPV vaccine makes dying from cervical cancer before 30 almost unheard of, with zero deaths recorded in women aged 20 to 24 over recent years. Commenters praised the result but argued over whether the headline oversold a risk that was already very low, while others stressed that boys and men should be in the conversation too.
This should have been a straightforward medical win, but the comments immediately turned it into a headline trial. The study itself is huge: researchers in England say girls who got the human papillomavirus (HPV) vaccine at 12 or 13 now have an almost zero chance of dying from cervical cancer before 30. Even more jaw-dropping, no women aged 20 to 24 died from cervical cancer in England between 2020 and 2024. That’s the kind of stat public health people dream about. The catch? Vaccine rates have dropped since the pandemic, and experts are warning that avoidable deaths could creep back up if fewer teenagers get the jab.
But the community? Oh, they were not going to let the headline strut around unchallenged. Several commenters basically yelled, “Hold on — almost zero from what starting number?” The biggest gripe was that deaths under 30 were already rare, so some readers felt the framing was a little too dramatic, even if the result is still excellent news. Others pushed the conversation in a broader direction, saying the story shouldn’t focus only on women because boys and men benefit too, with protection against other cancers as well. One practical voice cut through the stats battle to point out the obvious: even when cancer doesn’t kill, treatment can be brutal, expensive, and life-altering. So yes, the science got applause — but the comments delivered the classic internet combo of skepticism, fact-checking, and “please widen the lens” energy.
Key Points
- •A QMUL study published in *the Lancet* found that girls vaccinated against HPV at ages 12 or 13 have an almost zero risk of dying from cervical cancer before age 30.
- •The researchers estimate HPV vaccination has prevented nearly 200 young women from dying from cervical cancer in England since the program began.
- •For vaccinated women aged 30 to 34, the relative risk of death from cervical cancer was 63% lower, while little mortality change was seen in women never offered vaccination.
- •The article reports that no women aged 20 to 24 died from cervical cancer in England between 2020 and 2024.
- •Experts cited in the article warn that HPV vaccine uptake has fallen since the pandemic to 75% nationally and 60% in London, raising concern about future avoidable deaths.